PALVELLA THERAPEUTICS, INC. Depreciation, Depletion and Amortization in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Palvella Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2021 to 2023.
  • Palvella Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $605K, a 28.4% decline year-over-year.
  • Palvella Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.9M, a 31.3% decline from 2022.
  • Palvella Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.77M, a 12.6% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)

PALVELLA THERAPEUTICS, INC. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $605K -$240K -28.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $845K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11

PALVELLA THERAPEUTICS, INC. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.9M -$866K -31.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.77M +$311K +12.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $2.46M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.